Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bar

Showing results (301-310 of 337) with videos related to

Pageof 34
Sort By:
Annals of the New York Academy of Sciences|May 24, 2003
Extracellularly applied Br-TITU inhibits the Na+/K+ pump by interacting with tryptophan at the entrance to the cation sitesG A Yudowski, M Bar Shimon, R M González-Lebrero, et al.
Placenta|May 15, 2003
Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placentaJ Hempstock, Y-P Bao, M Bar-Issac, et al.
Oncogene|January 17, 2007
Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivoB Schwartz, V O Melnikova, C Tellez, et al.
The New England Journal of Medicine|May 25, 2022
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2Yair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Journal of Helminthology|June 1, 1977
Ecological control of hookworm and strongyloidiasisE G Goulart, M C Jourdan, R P Brazil, et al.
Acta Neurologica Scandinavica|August 24, 2012
Perampanel Study 207: long-term open-label evaluation in patients with epilepsyI Rektor, G L Krauss, M Bar, et al.
The Lancet. Infectious Diseases|September 12, 2022
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational studyOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|April 5, 2022
Protection by a Fourth Dose of BNT162b2 against Omicron in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Pageof 34

Showing results (301-310 of 337) with videos related to

Sort By:
Pageof 34
Annals of the New York Academy of Sciences|May 24, 2003
Extracellularly applied Br-TITU inhibits the Na+/K+ pump by interacting with tryptophan at the entrance to the cation sitesG A Yudowski, M Bar Shimon, R M González-Lebrero, et al.
Placenta|May 15, 2003
Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placentaJ Hempstock, Y-P Bao, M Bar-Issac, et al.
Oncogene|January 17, 2007
Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivoB Schwartz, V O Melnikova, C Tellez, et al.
The New England Journal of Medicine|May 25, 2022
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2Yair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Journal of Helminthology|June 1, 1977
Ecological control of hookworm and strongyloidiasisE G Goulart, M C Jourdan, R P Brazil, et al.
Acta Neurologica Scandinavica|August 24, 2012
Perampanel Study 207: long-term open-label evaluation in patients with epilepsyI Rektor, G L Krauss, M Bar, et al.
The Lancet. Infectious Diseases|September 12, 2022
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational studyOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|April 5, 2022
Protection by a Fourth Dose of BNT162b2 against Omicron in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Pageof 34